An insider at Oruka Therapeutics sold 105,000 shares valued at $6.2 million. Such a large sale by someone within the company could indicate changes in confidence or strategy. Investors should watch for further developments or official statements from Oruka Therapeutics to understand the implications. This move might impact the stock price depending on market reaction.
Modern Therapy Group has introduced a virtual intensive outpatient program (IOP) designed for adults dealing with depression, anxiety, trauma, and other mental health issues. This program offers structured, clinician-led treatment five days a week vi...
Meyer Wilson Werning, an investor protection law firm, is investigating UBS advisor Daniel Merithew Allen for allegedly recommending unapproved investments in 99 Acquisition Group LLC to clients. This practice, known as "selling away," violates FINRA...
NEWMEDIA.COM highlights a major shift in digital marketing where AI Visibility Infrastructure integrates search, authority, content, and analytics to ensure brands are discoverable and recommended by AI systems. Traditional search rankings are becomi...
The official $HODL coin, created by GameKyuubi—the original author of the famous 2013 "HODL" post—has expanded to Ethereum with a new 1:1 cross-chain bridge powered by LayerZero. This bridge allows holders to transfer $HODL tokens instantly between S...
The Boulder County Business Hall of Fame revealed its 2026 inductees, honoring seven influential figures from sectors like education, finance, law, immigrant entrepreneurship, and real estate. The inductees include Sandy and Sally Bracken, Gerry Agne...
